Nakamoto Inc Revenue Growth Rates (NAKA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Nakamoto Inc   (NASDAQ: NAKA)
 

NAKA's Revenue Growth by Quarter and Year

Nakamoto Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NAKA/growth
https://api.csimarket.com/api/v1/companies/NAKA/fundamentals
https://api.csimarket.com/api/v1/companies/NAKA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
NAKA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1.93
2nd Quarter June 25.45
1st Quarter March 2.68
FY 30.06





NAKA Revenue third quarter 2026 Y/Y Growth Comment
Nakamoto Inc achieved in the third quarter 2026, above Company average Revenue surge of 394.62% year on year, to $ 1.93 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 148 other companies have achieved higher Revenue growth. While Nakamoto Inc ' s Revenue doubling of 394.62% ranks overall at the positon no. 3122 in the third quarter 2026.


NAKA Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 394.62 %
2nd Quarter June 6107.32 %
1st Quarter March 362.07 %
FY   -

Financial Statements
Nakamoto Inc 's third quarter 2026 Revenue $ 1.93 millions NAKA's Income Statement
Nakamoto Inc 's third quarter 2025 Revenue $ 0.39 millions Quarterly NAKA's Income Statement


NAKA Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -92.42 %
2nd Quarter June 849.63 %
1st Quarter March 509.09 %
FY (Year on Year)   -


Back to NAKA Growth rate Comparisons >> Back to NAKA Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #149
Healthcare Sector #422
Overall #3122

Revenue Y/Y Growth Statistics
High Average Low
1192.99 % 188.61 % -33.04 %
(Jun 30 2026)   (Dec 31 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #149
Healthcare Sector #422
Overall #3122
Revenue Y/Y Growth Statistics
High Average Low
1192.99 % 188.61 % -33.04 %
(Jun 30 2026)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Nakamoto Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
850.37 % 97.67 % -29.52 %
(Jun 30 2026)  


NAKA's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Nakamoto Inc disclosed fall in Revenue from the second quarter by -92.42% to $ 1.93 millions, from $ 25.45 millions achived in the previous reporting period.

But that's not important problem, as Nakamoto Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry Nakamoto Inc achieved highest sequential Revenue growth. While Nakamoto Inc 's Revenue growth quarter on quarter, overall rank is 34.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #0
Healthcare Sector #12
Overall #34
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #0
Healthcare Sector #12
Overall #34
Revenue Q/Q Growth Statistics
High Average Low
850.37 % 97.67 % -29.52 %
(Jun 30 2026)  


NAKA's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Nakamoto Inc disclosed fall in Revenue from the second quarter by -92.42% to $ 1.93 millions, from $ 25.45 millions achived in the previous reporting period.

But that's not important problem, as Nakamoto Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry Nakamoto Inc achieved highest sequential Revenue growth. While Nakamoto Inc 's Revenue growth quarter on quarter, overall rank is 34.


Nakamoto Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 30.50
Y / Y Revenue Growth (TTM) 1440.34 %
Year on Year Revenue Growth Overall Ranking # 3429
Seqeuential Revenue Change (TTM) 5.32 %
Seq. Revenue Growth (TTM) Overall Ranking # 3122


Cumulative Revenue growth Comment
Nakamoto Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1440.34% year on year, to $ 31 millions if the fiscal year would have ended in Sep 30 2026.
Nakamoto Inc 's trailing twelve months Revenue growth was higher than company's average 188.61% and higher than 1192.99% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 5.32 % from $28.96 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at188.61%.

In the Healthcare sector 465 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2896 to 3429.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 466
Overall # 3429

Revenue TTM Y/Y Growth Statistics
High Average Low
1192.99 %
 188.61 %
-33.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 149
Sector # 422
S&P 500 # 3122
Cumulative Revenue growth Comment
Nakamoto Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1440.34% year on year, to $ 31 millions if the fiscal year would have ended in Sep 30 2026.
Nakamoto Inc 's trailing twelve months Revenue growth was higher than company's average 188.61% and higher than 1192.99% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 5.32 % from $28.96 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at188.61%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 5.32 % increase from $28.96 millions in the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 465 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2896 to 3429.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 466
Overall # 3429

Revenue TTM Y/Y Growth Statistics
High Average Low
1192.99 %
188.61 %
-33.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 149
Sector # 422
S&P 500 # 3122




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NAKA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Brightspring Health Services Inc 588.43%$ 588.428 millions
Bio Green Med Solution Inc 460.49%$ 460.494 millions
Xencor Inc454.88%$ 454.884 millions
Tonix Pharmaceuticals Holding Corp 423.83%$ 423.830 millions
Nakamoto Inc 396.90%$ 396.897 millions
EBR Systems, Inc.385.65%$ 385.647 millions
Solana Company382.07%$ 382.066 millions
Pulse Biosciences Inc 359.30%$ 359.302 millions
Ensysce Biosciences Inc 342.43%$ 342.428 millions
Nexalin Technology Inc 331.43%$ 331.434 millions
Agios Pharmaceuticals Inc 330.01%$ 330.008 millions
Insmed Inc330.00%$ 330.000 millions
Monte Rosa Therapeutics Inc 325.80%$ 325.799 millions
Liquidia Corporation314.60%$ 314.596 millions
Stablecoin Development Corporation310.75%$ 310.749 millions
Renovorx Inc 300.75%$ 300.752 millions
Aligos Therapeutics Inc 281.92%$ 281.916 millions
Clene Inc 273.33%$ 273.333 millions
Recursion Pharmaceuticals Inc 258.49%$ 258.493 millions
Nuvation Bio Inc 251.98%$ 251.977 millions
Seastar Medical Holding Corp246.99%$ 246.995 millions
Prime Medicine Inc 243.92%$ 243.918 millions
Urogen Pharma Ltd 227.16%$ 227.161 millions
Dianthus Therapeutics Inc 205.56%$ 205.556 millions


About Nakamoto Inc Revenue Growth Rates (NAKA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Nakamoto Inc (CIK 1946573).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-073455
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Nakamoto Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.